All News #Library
Biotech
Rona Therapeutics Launches First Global Bi-Valent PCSK9-LPA
17 Dec 2025 //
PR NEWSWIRE
Rona Therapeutics Progresses INHBE Sirna To Phase 1 Trial
15 Dec 2025 //
PR NEWSWIRE
Rona Therapeutics Announces IND Filing of RN3161 for Obesity
16 Sep 2025 //
#N/A
Rona Submits IND for GalNAc-Conjugated siRNA Targeting Obesity
16 Sep 2025 //
INDPHARMAPOST
Rona Therapeutics Files IND for Potent Obesity Drug RN3161
15 Sep 2025 //
PR NEWSWIRE
Rona Therapeutics Reveals Breakthrough Data on RNAi Therapy RN026
28 May 2025 //
PR NEWSWIRE
Rona Therapeutics: NMPA Approves IND for RN1871 siRNA Drug
21 Apr 2025 //
PR NEWSWIRE
Rona Therapeutics gets FDA clearance for Phase 2 study of RN0361
17 Mar 2025 //
PR NEWSWIRE
Rona Presents Ph 1 Data on RN0191 at (AHA) Scientific Sessions
17 Nov 2024 //
PR NEWSWIRE

Market Place
Sourcing Support